https://www.pharmamanufacturing.com/industry-news/news/55415982/fresenius-wuxi-biologics-ink-exclusive-agreement-to-develop-biosimilarsPharma Manufacturingen2026-11-02T17:33:24.000ZFresenius, WuXi Biologics ink exclusive agreement to develop biosimilarshttps://www.pharmamanufacturing.com/industry-news/news/55415980/milliporesigma-opens-335m-bioprocessing-center-in-south-koreaPharma Manufacturingen2026-11-02T17:31:40.000ZMilliporeSigma opens $335M bioprocessing center in South Korea